1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Precision Psychiatry Market Size 2016-2026
  • 2.1.2 Precision Psychiatry Market Size CAGR by Region 2020 VS 2021 VS 2026
• 2.2 Precision Psychiatry Segment by Type
  • 2.2.1 Products
  • 2.2.2 Products
• 2.3 Precision Psychiatry Market Size by Type
  • 2.3.1 Global Precision Psychiatry Market Size CAGR by Type
  • 2.3.2 Global Precision Psychiatry Market Size Market Share by Type (2016-2021)
• 2.4 Precision Psychiatry Segment by Application
  • 2.4.1 Hospitals and Diagnostic Laboratories
  • 2.4.2 Academic and Research Institutions
  • 2.4.3 Others
• 2.5 Precision Psychiatry Market Size by Application
  • 2.5.1 Global Precision Psychiatry Market Size CAGR by Application
  • 2.5.2 Global Precision Psychiatry Market Size Market Share by Application (2016-2021)

3 Precision Psychiatry Market Size by Players

• 3.1 Precision Psychiatry Market Size Market Share by Players
  • 3.1.1 Global Precision Psychiatry Revenue by Players (2019-2021E)
  • 3.1.2 Global Precision Psychiatry Revenue Market Share by Players (2019-2021E)
• 3.2 Global Precision Psychiatry Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Precision Psychiatry by Regions

• 4.1 Precision Psychiatry Market Size by Regions (2016-2021)
• 4.2 Americas Precision Psychiatry Market Size Growth (2016-2021)
• 4.3 APAC Precision Psychiatry Market Size Growth (2016-2021)
• 4.4 Europe Precision Psychiatry Market Size Growth (2016-2021)
• 4.5 Middle East & Africa Precision Psychiatry Market Size Growth (2016-2021)

5 Americas

• 5.1 Americas Precision Psychiatry Market Size by Country (2016-2021)
• 5.2 Americas Precision Psychiatry Market Size by Type (2016-2021)
• 5.3 Americas Precision Psychiatry Market Size by Application (2016-2021)
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Precision Psychiatry Market Size by Region (2016-2021)
• 6.2 APAC Precision Psychiatry Market Size by Type (2016-2021)
• 6.3 APAC Precision Psychiatry Market Size by Application (2016-2021)
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe Precision Psychiatry by Country (2016-2021)
• 7.2 Europe Precision Psychiatry Market Size by Type (2016-2021)
• 7.3 Europe Precision Psychiatry Market Size by Application (2016-2021)
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Precision Psychiatry by Region (2016-2021)
• 8.2 Middle East & Africa Precision Psychiatry Market Size by Type (2016-2021)
• 8.3 Middle East & Africa Precision Psychiatry Market Size by Application (2016-2021)
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Precision Psychiatry Market Forecast

• 10.1 Global Precision Psychiatry Forecast by Regions (2021-2026)
  • 10.1.1 Global Precision Psychiatry Forecast by Regions (2021-2026)
  • 10.1.2 Americas Precision Psychiatry Forecast
  • 10.1.3 APAC Precision Psychiatry Forecast
  • 10.1.4 Europe Precision Psychiatry Forecast
  • 10.1.5 Middle East & Africa Precision Psychiatry Forecast
• 10.2 Americas Precision Psychiatry Forecast by Countries (2021-2026)
  • 10.2.1 United States Precision Psychiatry Market Forecast
  • 10.2.2 Canada Precision Psychiatry Market Forecast
  • 10.2.3 Mexico Precision Psychiatry Market Forecast
  • 10.2.4 Brazil Precision Psychiatry Market Forecast
• 10.3 APAC Precision Psychiatry Forecast by Region (2021-2026)
  • 10.3.1 China Precision Psychiatry Market Forecast
  • 10.3.2 Japan Precision Psychiatry Market Forecast
  • 10.3.3 Korea Precision Psychiatry Market Forecast
  • 10.3.4 Southeast Asia Precision Psychiatry Market Forecast
  • 10.3.5 India Precision Psychiatry Market Forecast
  • 10.3.6 Australia Precision Psychiatry Market Forecast
• 10.4 Europe Precision Psychiatry Forecast by Country (2021-2026)
  • 10.4.1 Germany Precision Psychiatry Market Forecast
  • 10.4.2 France Precision Psychiatry Market Forecast
  • 10.4.3 UK Precision Psychiatry Market Forecast
  • 10.4.4 Italy Precision Psychiatry Market Forecast
  • 10.4.5 Russia Precision Psychiatry Market Forecast
• 10.5 Middle East & Africa Precision Psychiatry Forecast by Region (2021-2026)
  • 10.5.1 Egypt Precision Psychiatry Market Forecast
  • 10.5.2 South Africa Precision Psychiatry Market Forecast
  • 10.5.3 Israel Precision Psychiatry Market Forecast
  • 10.5.4 Turkey Precision Psychiatry Market Forecast
  • 10.5.5 GCC Countries Precision Psychiatry Market Forecast
• 10.6 Global Precision Psychiatry Forecast by Type (2021-2026)
• 10.7 Global Precision Psychiatry Forecast by Application (2021-2026)

11 Key Players Analysis

• 11.1 llumina, Inc
  • 11.1.1 llumina, Inc Company Information
  • 11.1.2 llumina, Inc Precision Psychiatry Product Offered
  • 11.1.3 llumina, Inc Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 llumina, Inc Main Business Overview
  • 11.1.5 llumina, Inc Latest Developments
• 11.2 F. Hoffmann-La Roche Ltd.
  • 11.2.1 F. Hoffmann-La Roche Ltd. Company Information
  • 11.2.2 F. Hoffmann-La Roche Ltd. Precision Psychiatry Product Offered
  • 11.2.3 F. Hoffmann-La Roche Ltd. Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  • 11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
• 11.3 Bio-Rad Laboratories, Inc.
  • 11.3.1 Bio-Rad Laboratories, Inc. Company Information
  • 11.3.2 Bio-Rad Laboratories, Inc. Precision Psychiatry Product Offered
  • 11.3.3 Bio-Rad Laboratories, Inc. Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 Bio-Rad Laboratories, Inc. Main Business Overview
  • 11.3.5 Bio-Rad Laboratories, Inc. Latest Developments
• 11.4 QIAGEN N.V.
  • 11.4.1 QIAGEN N.V. Company Information
  • 11.4.2 QIAGEN N.V. Precision Psychiatry Product Offered
  • 11.4.3 QIAGEN N.V. Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 QIAGEN N.V. Main Business Overview
  • 11.4.5 QIAGEN N.V. Latest Developments
• 11.5 Quest Diagnostics Incorporated
  • 11.5.1 Quest Diagnostics Incorporated Company Information
  • 11.5.2 Quest Diagnostics Incorporated Precision Psychiatry Product Offered
  • 11.5.3 Quest Diagnostics Incorporated Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 Quest Diagnostics Incorporated Main Business Overview
  • 11.5.5 Quest Diagnostics Incorporated Latest Developments
• 11.6 ARUP Laboratories
  • 11.6.1 ARUP Laboratories Company Information
  • 11.6.2 ARUP Laboratories Precision Psychiatry Product Offered
  • 11.6.3 ARUP Laboratories Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 ARUP Laboratories Main Business Overview
  • 11.6.5 ARUP Laboratories Latest Developments
• 11.7 Invitae Corporation
  • 11.7.1 Invitae Corporation Company Information
  • 11.7.2 Invitae Corporation Precision Psychiatry Product Offered
  • 11.7.3 Invitae Corporation Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 Invitae Corporation Main Business Overview
  • 11.7.5 Invitae Corporation Latest Developments
• 11.8 OPKO Health, Inc.
  • 11.8.1 OPKO Health, Inc. Company Information
  • 11.8.2 OPKO Health, Inc. Precision Psychiatry Product Offered
  • 11.8.3 OPKO Health, Inc. Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 OPKO Health, Inc. Main Business Overview
  • 11.8.5 OPKO Health, Inc. Latest Developments
• 11.9 Laboratory Corporation of America Holdings
  • 11.9.1 Laboratory Corporation of America Holdings Company Information
  • 11.9.2 Laboratory Corporation of America Holdings Precision Psychiatry Product Offered
  • 11.9.3 Laboratory Corporation of America Holdings Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 Laboratory Corporation of America Holdings Main Business Overview
  • 11.9.5 Laboratory Corporation of America Holdings Latest Developments
• 11.10 Centogene N.V.
  • 11.10.1 Centogene N.V. Company Information
  • 11.10.2 Centogene N.V. Precision Psychiatry Product Offered
  • 11.10.3 Centogene N.V. Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 Centogene N.V. Main Business Overview
  • 11.10.5 Centogene N.V. Latest Developments

11. Thermo Fisher Scientific Inc.

• 11.11.1 Thermo Fisher Scientific Inc. Company Information
• 11.11.2 Thermo Fisher Scientific Inc. Precision Psychiatry Product Offered
• 11.11.3 Thermo Fisher Scientific Inc. Precision Psychiatry Revenue, Gross Margin and Market Share (2019-2021)
• 11.11.4 Thermo Fisher Scientific Inc. Main Business Overview

According to this latest study, the 2021 growth of Precision Psychiatry will have significant change from previous year. By the most conservative estimates of global Precision Psychiatry market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Precision Psychiatry market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Precision Psychiatry market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Products
Services

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals and Diagnostic Laboratories
Academic and Research Institutions
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
llumina, Inc
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
ARUP Laboratories
Invitae Corporation
OPKO Health, Inc.
Laboratory Corporation of America Holdings
Centogene N.V.
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
Konica Minolta, Inc.
Fulgent Genetics
PreventionGenetics